Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

Freedberg, D.E., Conigliaro, J., Wang, T.C., Tracey, K.J., Callahan, M.V., Abrams, J.A., On behalf of the Famotidine Research Group, Famotidine Research Group, Sobieszczyk, M.E., Markowitz, D.D., Gupta, A., O'Donnell, M.R., Li, J., Tuveson, D.A., Jin, Z., Turner, W.C., Landry, D.W. (May 2020) Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology. ISSN 0016-5085

URL: https://pubmed.ncbi.nlm.nih.gov/32446698/
DOI: 10.1053/j.gastro.2020.05.053
Item Type: Paper
Subjects: diseases & disorders > viral diseases > coronavirus
diseases & disorders > cancer > drugs and therapies
CSHL Authors:
Communities: CSHL Cancer Center Program
CSHL labs > Tuveson lab
Depositing User: Adrian Gomez
Date: 21 May 2020
Date Deposited: 01 Jun 2020 14:14
Last Modified: 17 Sep 2020 16:18
PMCID: PMC7242191
Related URLs:
URI: https://repository.cshl.edu/id/eprint/39482

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving